Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

Gisbert JP Loras C, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa) REPENTINA study, Javier Calvet Calvo

Research output: Contribution to journalArticleResearch

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)1529-1538
JournalJ. Crohns Colitis
Volume8
Publication statusPublished - 1 Jan 2014

Cite this